PURPOSE: High coronary artery calcium (CAC) scores are associated with a high likelihood of ischaemia and obstructive coronary disease. Myocardial perfusion imaging (MPI) is a key investigation to determine the need for revascularization. However, the value of MPI in presence of extensive CAC has so far only been demonstrated in asymptomatic patients, whereas its value in symptomatic patients remains largely unclear. Therefore, we studied the impact of MPI in symptomatic patients with a CAC score ≥ 1,000. METHODS: We included 282 patients (mean age 69 ± 9 years, 63% men) without a history of coronary disease with suspected stable angina referred for MPI and with a CAC score ≥ 1,000. On follow-up at 18 months invasive angiography, coronary revascularization, nonfatal myocardial infarction and death were recorded. RESULTS: MPI was normal in 54 %, equivocal in 10 % and abnormal in 37 % (fixed defect 9 % and ischaemia 28 %) of patients. More abnormal MPI findings were observed in men, smokers and those with even higher CAC scores. During follow-up, 1 patient (with nonischaemic MPI) died from a cardiac cause, 1 patient (with ischaemic MPI) suffered a myocardial infarction and 92 patients (33 %) underwent revascularization. Ischaemia on MPI was a strong predictor of coronary revascularization (odds ratio 13.1; 95 % CI 7.1-24.3; p < 0.001). CONCLUSION: Ischaemia on MPI is observed in approximately 30 % of patients with a CAC score ≥ 1,000, and is a strong predictor of coronary revascularization. However, nonischaemic MPI does not exclude revascularization, and patients with persisting complaints should be considered for invasive angiography.
PURPOSE: High coronary artery calcium (CAC) scores are associated with a high likelihood of ischaemia and obstructive coronary disease. Myocardial perfusion imaging (MPI) is a key investigation to determine the need for revascularization. However, the value of MPI in presence of extensive CAC has so far only been demonstrated in asymptomatic patients, whereas its value in symptomatic patients remains largely unclear. Therefore, we studied the impact of MPI in symptomatic patients with a CAC score ≥ 1,000. METHODS: We included 282 patients (mean age 69 ± 9 years, 63% men) without a history of coronary disease with suspected stable angina referred for MPI and with a CAC score ≥ 1,000. On follow-up at 18 months invasive angiography, coronary revascularization, nonfatal myocardial infarction and death were recorded. RESULTS: MPI was normal in 54 %, equivocal in 10 % and abnormal in 37 % (fixed defect 9 % and ischaemia 28 %) of patients. More abnormal MPI findings were observed in men, smokers and those with even higher CAC scores. During follow-up, 1 patient (with nonischaemic MPI) died from a cardiac cause, 1 patient (with ischaemic MPI) suffered a myocardial infarction and 92 patients (33 %) underwent revascularization. Ischaemia on MPI was a strong predictor of coronary revascularization (odds ratio 13.1; 95 % CI 7.1-24.3; p < 0.001). CONCLUSION:Ischaemia on MPI is observed in approximately 30 % of patients with a CAC score ≥ 1,000, and is a strong predictor of coronary revascularization. However, nonischaemic MPI does not exclude revascularization, and patients with persisting complaints should be considered for invasive angiography.
Authors: Kevin A Bybee; John Lee; Richard Markiewicz; Ryan Longmore; A Iain McGhie; James H O'Keefe; Bai-Ling Hsu; Kevin Kennedy; Randall C Thompson; Timothy M Bateman Journal: J Nucl Cardiol Date: 2009-12-11 Impact factor: 5.952
Authors: Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal Journal: N Engl J Med Date: 2008-03-27 Impact factor: 91.245
Authors: E L Jones; S B King; J M Craver; J S Douglas; J A Kaplan; E A Morgan; E M Brown; J M Bradford; C R Hatcher Journal: J Thorac Cardiovasc Surg Date: 1980-01 Impact factor: 5.209
Authors: Su Min Chang; Faisal Nabi; Jiaqiong Xu; Leif E Peterson; Arup Achari; Craig M Pratt; John J Mahmarian Journal: J Am Coll Cardiol Date: 2009-11-10 Impact factor: 24.094
Authors: Neuza Helena Lopes; Felipe da Silva Paulitsch; Aécio F Gois; Alexandre C Pereira; Noedir A Stolf; Luis Oliveira Dallan; José A F Ramires; Whady A Hueb Journal: Eur J Cardiothorac Surg Date: 2008-01-30 Impact factor: 4.191
Authors: Elsemiek M Engbers; Jorik R Timmer; Jan Paul Ottervanger; Mohamed Mouden; Ad H J Oostdijk; Siert Knollema; Pieter L Jager Journal: J Nucl Cardiol Date: 2015-09-22 Impact factor: 5.952
Authors: Sana Shah; Naveen Bellam; Jonathon Leipsic; Daniel S Berman; Arshed Quyyumi; Jörg Hausleiter; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Fillippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Benjamin J W Chow; Ricardo C Cury; Augustin J Delago; Allison L Dunning; Gudrun M Feuchtner; Martin Hadamitzky; Ronald P Karlsberg; Philipp A Kaufmann; Fay Y Lin; Kavitha M Chinnaiyan; Erica Maffei; Gilbert L Raff; Todd C Villines; Millie J Gomez; James K Min; Leslee J Shaw Journal: J Nucl Cardiol Date: 2014-03-29 Impact factor: 5.952
Authors: Elsemiek M Engbers; Jorik R Timmer; Mohamed Mouden; Siert Knollema; Pieter L Jager; Jan Paul Ottervanger Journal: Eur Radiol Date: 2016-05-11 Impact factor: 5.315
Authors: Shu Yokota; Jan Paul Ottervanger; Mohamed Mouden; Jorik R Timmer; Siert Knollema; Pieter L Jager Journal: J Nucl Cardiol Date: 2014-01-28 Impact factor: 5.952